October 2011

Dr. Reddy's Laboratories (NYSE: RDY) is an emerging global pharmaceutical company with proven research capabilities. The company is vertically integrated with a presence across the pharmaceutical value chain. It produces finished dosage forms, active pharmaceutical ingredients and biotechnology products and markets them globally, with focus on India, US, Europe and Russia.

Aizant is an integrated drug development solutions provider. Aizant was established by experienced pharmaceutical professionals with global exposure.
Aizant is a rapidly growing contract research organization (CRO) with a diverse portfolio of capabilities partnering with health care companies specializing in new molecular entities (NME’s), generics (ANDA’s) and over the counter (OTC’s) products globally.

Inga Laboratories P. Ltd., a research-based pharmaceutical corporation, was established in 1974. The company’s activities are focused to the development, manufacture and marketing of pharmaceutical formulations at affordable prices.
Inga Laboratories P. Ltd. manufactures galenical forms such as tablets, capsules, liquid orals, injectables and beta lactum formulations in compliance with the latest current Good Manufacturing Practices.

Arch Pharmalabs has gained recognition as a world-class provider of small molecule process chemistry, custom synthesis services and full life-cycle API and drug intermediates manufacture for the global pharmaceutical industry. Generating revenues of USD 200 million, our India-based offering is supported by 2,400 customer-centric Archers, eleven certified facilities (including cGMP-compliant, US FDA- and EDQM-approved sites) and two state-of-the-art Process Technology centres.